AccueilBURE • STO
add
Bure Equity
Dernière clôture
404,40 kr
Variation sur la journée
404,20 kr - 417,00 kr
Plage sur l'année
203,60 kr - 417,00 kr
Capitalisation boursière
29,99 Md SEK
Volume moyen
54,60 k
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
STO
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
(SEK) | juin 2024info | Variation Y/Y |
---|---|---|
Chiffre d'affaires | 1,78 Md | 137,33 % |
Charges d'exploitation | 25,00 M | 13,64 % |
Résultat net | 1,76 Md | 141,64 % |
Marge bénéficiaire nette | 99,10 | 1,82 % |
Bénéfice par action | — | — |
EBITDA | 1,76 Md | 140,88 % |
Taux d'imposition effectif | — | — |
Bilan
Total des actifs
Total du passif
(SEK) | juin 2024info | Variation Y/Y |
---|---|---|
Trésorerie/Invest. court terme | 1,53 Md | 394,17 % |
Total des actifs | 23,75 Md | 35,17 % |
Total du passif | 49,00 M | 16,67 % |
Total des capitaux propres | 23,70 Md | — |
Actions en circulation | 74,15 M | — |
Ratio cours/valeur comptable | 1,27 | — |
Rentabilité des actifs | 19,11 % | — |
Retour sur capitaux | 19,15 % | — |
Flux de trésorerie
Variation nette en trésorerie
(SEK) | juin 2024info | Variation Y/Y |
---|---|---|
Résultat net | 1,76 Md | 141,64 % |
Trésorerie (opérations) | 139,00 M | 28,70 % |
Trésorerie (invest.) | 180,00 M | — |
Trésorerie (financement) | -187,00 M | -9,36 % |
Variation nette en trésorerie | 132,00 M | 309,52 % |
Flux de trésorerie dispo. | 1,10 Md | 141,73 % |
À propos
Bure Equity is a Swedish investment company involved in communications, textiles, training, and education. It is the largest private school operator in Sweden. Bure Equity owns Vittra, a company that runs schools in Sweden and other countries.
On February 11, 2009, Altor Fund III and Bure Equity AB signed an agreement to acquire Carnegie Investment Bank, a leading independent Nordic investment bank, from the Swedish National Debt Office. The total net asset value on 31 December 2016 amounted to six billion kroner and the largest holdings were in the companies Mycronic and Vitrolife. The company also has shares in, among others, the industrial company Cavotec, the pharmaceutical company MedCap, the medical technology company Xvivo Perfusion and the auction company Lauritz.com.
Henrik Blomquist took over as CEO in 2014.
On 20 January, 2022, Bure sold their locomotive leasing business for an undisclosed amount. Wikipedia
Date de fondation
1992
Site Web
Employés
12